A clinical investigation of early‐onset alopecia areata in children: Onset earlier than 4 years of age might have a better short‐term prognosis

Abstract

AbstractAlopecia areata (AA) is a non‐scarring autoimmune hair loss of the scalp or body. While an early onset is considered a primary factor for poor prognosis, children with early‐onset AA show varied responses to treatment. This study aimed to describe the clinical characteristics and assess the prognostic factors of early‐onset AA in children. We performed a retrospective study of AA patients aged <10 years who visited our dermatologic clinic between January 2013 and December 2020, with a follow‐up period >12 months. A clinical review of medical records, photographs, and telephonic interviews was performed. Treatment efficacy was assessed based on the degree of hair regrowth at a 12‐month follow‐up. Of 162 patients treated with topical corticosteroids, alone or in combination with other modalities, 57.4% showed >50% hair regrowth. On comparing the good and poor treatment response groups, no significant differences were observed in the presence of known prognostic factors, except for personal atopic history. In addition, patients aged <4 years at onset responded significantly better than older patients (p = 0.0127). There is a possibility that the patients with early‐onset AA, especially those aged <4 years, demonstrate good treatment response. Further studies on long‐term prognosis are required.